Montefiore

Phone
Menu

Terms and Conditions

Welcome to Montefiore Dental! By accessing or using our website (https://www.montefioredental.com/) and purchasing our products, including semaglutide products, you agree to abide by the following Terms and Conditions. Please read them carefully before proceeding.

1. Acceptance of Terms

By using this website, you confirm that you are at least 18 years old and capable of entering into a legally binding agreement. If you disagree with any part of these Terms and Conditions, you must not use our website.

2. Products and Services

Montefiore Dental specializes in offering semaglutide and related products. All products are intended for lawful use only, and it is your responsibility to ensure compliance with applicable laws in your jurisdiction.

3. Medical Disclaimer

The information provided on this website is for educational and informational purposes only.

  • Products are not intended to diagnose, treat, cure, or prevent any disease.
  • Always consult a licensed healthcare provider before using any medication or product, including semaglutide.
  • Montefiore Dental is not responsible for any adverse effects or outcomes resulting from improper use.

4. Ordering and Payment

  • All orders must be placed through our website.
  • We reserve the right to refuse or cancel any order for reasons such as inaccurate pricing or product availability.
  • Payment must be completed at the time of purchase using the payment methods provided.

5. Shipping and Returns

  • Shipping policies, including timelines and costs, are detailed on our Shipping Policy page.
  • Refunds or exchanges may be available for eligible items under our Return Policy. Please review these policies for details.

6. Privacy Policy

Your use of this website is also governed by our Privacy Policy, which outlines how we collect, use, and protect your information.

7. Limitation of Liability

Montefiore Dental is not liable for any direct, indirect, incidental, or consequential damages arising from the use of our website, products, or services.

8. Intellectual Property

All content, including text, images, logos, and trademarks, on this website is the property of Montefiore Dental and is protected by copyright laws. You may not reproduce, distribute, or modify any content without prior written consent.

9. Modifications to Terms

Montefiore Dental reserves the right to modify these Terms and Conditions at any time. Changes will be effective upon posting to the website.

10. Governing Law

These Terms and Conditions are governed by the laws of NJ, without regard to conflict of law principles.

11. Contact Information

For any questions or concerns regarding these Terms and Conditions, please contact us at:
Email: support@montefioredental.com

Last Updated: 12.24.2024

Medication Disclaimer

Essential Information on Medications: Saxenda®, Victoza®, Wegovy®, and Ozempic® are patented products of Novo Nordisk™, while Eli Lilly and Company™ produce Mounjaro™ and Zepbound. This website is not affiliated with, endorsed by, or connected to these companies or their products in any capacity. While these FDA-approved medications may be available through other sources, we do not provide them, and they are currently experiencing supply shortages. During such shortages, pharmacies might prepare compounded versions of these drugs, provided they comply with the Federal Food, Drug, and Cosmetic Act’s requirements. Compounded medications are valuable for patients with unique medical needs that FDA-approved drugs cannot address. However, it is important to note that compounded drugs are not FDA-approved, nor do they undergo premarketing evaluations for safety, effectiveness, or quality. The FDA has not assessed these medications for their intended uses, nor has the manufacturing process for compounded drugs been reviewed by the FDA.

Safety Information

Critical Details About Compounded Semaglutide

Compounded medications are legally allowed to be prescribed under federal law; however, they are not FDA-approved and do not undergo FDA evaluation for safety, efficacy, or production standards. At MontefioreDental, compounded semaglutide is prescribed based on an individualized medical assessment.

WARNING: Potential Risk of Thyroid C-Cell Tumors
Research in animals has linked semaglutide, the active ingredient in some GLP-1 receptor agonists, to thyroid tumors, including medullary thyroid carcinoma (MTC). It is unclear if semaglutide causes similar tumors in humans. Notify your healthcare provider immediately if you notice symptoms of thyroid cancer, such as neck lumps or swelling, hoarseness, swallowing difficulties, or shortness of breath. Compounded semaglutide is not suitable for individuals with personal or family histories of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Uses of Compounded Semaglutide
Compounded semaglutide is intended for use alongside a reduced-calorie diet and increased physical activity to manage chronic weight in adults who meet the following criteria:

  • A body mass index (BMI) of 30 kg/m² or higher (classified as obesity), or
  • A BMI of 27 kg/m² or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, hypertension, or abnormal cholesterol levels.

Usage Restrictions

  • Do not use compounded semaglutide in combination with other GLP-1 receptor agonists or semaglutide-containing products.
  • Its safety and effectiveness when combined with other weight management medications have not been established.
  • Patients with a history of pancreatitis or gastroparesis have not been studied for this treatment.

Avoid Use If You:

  • Have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
  • Are diagnosed with type 1 diabetes, pancreatitis, or gastroparesis.
  • Are allergic to semaglutide or any inactive ingredients.
  • Have a history of suicidal thoughts or behavior.

Precautions and Warnings:

  • Acute Pancreatitis: Stop using the medication if pancreatitis is suspected.
  • Gallbladder Issues: Monitor for symptoms of gallbladder disease, including gallstones, and seek medical advice as needed.
  • Low Blood Sugar: When combined with insulin or similar medications, there is an increased risk of hypoglycemia. Regularly monitor blood sugar and adjust doses as recommended by your provider.
  • Kidney Health: Monitor kidney function, particularly in patients with renal impairment or those experiencing severe gastrointestinal effects.
  • Mental Health Concerns: Watch for mood changes, depression, or suicidal thoughts, and discontinue use if these symptoms occur.

Pregnancy and Fertility Considerations
Semaglutide may harm an unborn child. Avoid use during pregnancy or if planning to become pregnant. Stop treatment at least two months before attempting to conceive.

Common Side Effects:
Frequently reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, headaches, and low blood sugar in patients with type 2 diabetes.

Potential Drug Interactions:
Compounded semaglutide slows gastric emptying, which could impact the absorption of oral medications. Consult your healthcare provider to manage potential interactions effectively.